RXST RxSight, Inc.companySEC Filings & Insider Trading Activity 2026
Latest RxSight, Inc. (RXST) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 25, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on March 19, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for RxSight, Inc. (RXST) (SEC CIK 1111485), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 5.02: Departure/Appointment of Directors or Principal Officers
- • CFO Mark Wilterding received $169,348.10 sign-on bonus paid March 13, 2026, per employment agreement
- • Stock option vesting corrected: 25% after 1 year, remaining monthly over 3 years, fully vested after 4 years from Jan 11, 2026
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released Feb 25, 2026; covers period ending Dec 31, 2025
- • Full financial results in Exhibit 99.1 press release — primary source for revenue, margins, and guidance
Recent 8-K FilingsCurrent Reports
AI-powered analysis of RxSight, Inc. (RXST) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 19, 2026 | — | Analysis | — |
10-K | Feb 25, 2026 | Dec 31, 2025 | — | |
8-K | Feb 25, 2026 | — | Analysis | — |
8-K | Jan 12, 2026 | — | — | |
8-K | Dec 23, 2025 | — | — | |
8-K | Dec 22, 2025 | — | — | |
8-K | Dec 19, 2025 | — | — | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 7, 2025 | Mar 31, 2025 | — | |
10-K | Feb 25, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 5, 2024 | Jun 30, 2024 | — | |
10-Q | May 6, 2024 | Mar 31, 2024 | — | |
10-K | Feb 28, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 7, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Mar 6, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 7, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 8, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Mar 8, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 10, 2021 | Sep 30, 2021 | — | |
10-Q | Sep 9, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest RXST SEC filings in 2026?
RxSight, Inc. (RXST) has filed a 10-K annual report on February 25, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on March 19, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did RXST file its most recent 10-K annual report?
RxSight, Inc. (RXST) filed its most recent 10-K annual report on February 25, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view RXST 10-Q quarterly reports?
RxSight, Inc. (RXST)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every RXST 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has RXST filed recently?
RxSight, Inc. (RXST)'s most recent 8-K was filed on March 19, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find RXST insider trading activity (Form 4)?
SignalX aggregates every RXST Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does RXST file with the SEC?
RxSight, Inc. (RXST) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new RXST filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for RxSight, Inc. (RXST).
What is RXST's SEC CIK number?
RxSight, Inc. (RXST)'s SEC CIK (Central Index Key) number is 1111485. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1111485 to look up all RXST filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find RXST return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from RxSight, Inc. (RXST) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of RxSight, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 25+ filings.